Hill-Rom Holdings, Inc. (HRC) Shares Bought by W.E. Donoghue & Co. LLC

W.E. Donoghue & Co. LLC lifted its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 101.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,466 shares of the medical technology company’s stock after purchasing an additional 5,281 shares during the period. W.E. Donoghue & Co. LLC’s holdings in Hill-Rom were worth $988,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of HRC. Vigilant Capital Management LLC bought a new position in shares of Hill-Rom in the second quarter worth about $109,000. Flagship Harbor Advisors LLC bought a new position in shares of Hill-Rom in the second quarter worth about $173,000. CIBC Asset Management Inc bought a new position in shares of Hill-Rom in the second quarter worth about $203,000. CAPROCK Group Inc. bought a new position in shares of Hill-Rom in the third quarter worth about $211,000. Finally, Hartford Investment Management Co. bought a new position in shares of Hill-Rom in the second quarter worth about $215,000. Hedge funds and other institutional investors own 81.14% of the company’s stock.

Shares of Hill-Rom stock opened at $83.53 on Friday. The company has a current ratio of 1.58, a quick ratio of 1.18 and a debt-to-equity ratio of 1.24. Hill-Rom Holdings, Inc. has a 1 year low of $75.21 and a 1 year high of $98.96. The stock has a market cap of $5.55 billion, a price-to-earnings ratio of 18.81, a price-to-earnings-growth ratio of 1.18 and a beta of 0.89.



Hill-Rom (NYSE:HRC) last issued its earnings results on Friday, July 27th. The medical technology company reported $1.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.02. Hill-Rom had a net margin of 8.19% and a return on equity of 20.54%. The company had revenue of $708.60 million for the quarter, compared to analysts’ expectations of $707.50 million. During the same period in the prior year, the business earned $0.91 EPS. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. As a group, equities research analysts forecast that Hill-Rom Holdings, Inc. will post 4.64 earnings per share for the current fiscal year.

HRC has been the topic of a number of research analyst reports. Zacks Investment Research upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a report on Monday, July 2nd. KeyCorp increased their target price on shares of Hill-Rom from $97.00 to $115.00 and gave the stock an “overweight” rating in a report on Tuesday, July 17th. Raymond James increased their target price on shares of Hill-Rom from $97.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, July 30th. Northcoast Research reiterated a “buy” rating and set a $104.00 target price on shares of Hill-Rom in a report on Tuesday, July 31st. Finally, ValuEngine upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating in a report on Tuesday, July 31st. Six research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Hill-Rom presently has an average rating of “Hold” and an average target price of $99.44.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Read More: Outstanding Shares and The Effect on Share Price

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply